Why People Stop GLP-1s in the First 90 Days

Medical disclaimer: This article is for general education only. It is not medical advice and is not a substitute for care from your healthcare provider. GLP-1 and GLP-1-related medications are prescription medications. Your prescriber should guide decisions about starting, continuing, pausing, stopping, restarting, or changing your medication. If you are thinking about stopping your medication for any reason, talk with your healthcare provider first.

A lot of people start a GLP-1 medication with hope.

Hope that their appetite will feel different.

Hope that food noise will get quieter.

Hope that blood sugar, weight, mobility, energy, or long-term health may improve.

Hope that this time will feel different from every other attempt.

And for many people, it does feel different.

But staying on a GLP-1 or GLP-1-related medication can be harder than people expect, especially in the first few months. Research and real-world data show that many people stop early, and the reasons are often more complicated than “it did not work.”

Cost gets in the way.

Side effects can feel overwhelming.

Expectations may not match reality.

The scale may move slower than expected.

A plateau may feel like failure.

People may not realize these medications are often thought about as long-term treatment, not a short course.

And many people are left to figure out the hardest early weeks with too little support between appointments.

This article is not here to tell you to stay on a medication. That decision belongs with you and your healthcare provider.

It is here to explain why people often stop, why the first 90 days can be so vulnerable, and what kind of support may help people make more informed decisions instead of feeling like they have to guess.

First, the financial barrier is real

Cost deserves to be named first.

For many people, the biggest reason for stopping a GLP-1 medication is not side effects, motivation, or expectations. It is money.

Insurance denials, coverage changes, expired savings cards, shortages, and high out-of-pocket costs can make these medications hard or impossible to continue.

That is not a personal failure. It is an access problem.

If a medication is not financially sustainable, then it is not truly accessible. No amount of mindset, planning, or support can fully solve a structural cost barrier.

That matters because conversations about GLP-1 discontinuation can become unfair very quickly. People may assume someone stopped because they “gave up,” when the reality may be that coverage ended, the pharmacy could not fill the prescription, or the monthly cost became impossible.

Support matters, but access matters too.

Side effects are one of the biggest early reasons people stop

After cost, side effects are one of the most common reasons people stop GLP-1 treatment.

This is especially true in the beginning.

GLP-1 medications affect digestion, appetite, and fullness. That is part of how they work. But those same effects can also cause uncomfortable symptoms, especially when someone first starts medication or moves to a higher dose.

Common side effects can include:

• Nausea.
• Vomiting.
• Diarrhea.
• Constipation.
• Bloating.
• Stomach discomfort.
• Reflux-like symptoms.
• Fatigue.
• Headache.

Some people have mild symptoms that improve as their body adjusts. Others have symptoms that are harder to manage. Some side effects may be temporary, but they can still feel intense in the moment.

That is one reason the first 90 days matter so much. The period when the body is adjusting may also be the period when someone is most likely to question whether the medication is worth it.

If someone is nauseated, constipated, exhausted, unsure what to eat, and waiting weeks for their next appointment, stopping may feel like the only option.

The problem is not always the side effect itself. Sometimes it is the lack of support around it.

Side effects are harder when they happen without context.

A person may not know whether nausea is common or concerning.

They may not know whether constipation is something to track or something to call about.

They may not know what to eat when nothing sounds good.

They may not know whether they are drinking enough.

They may not know whether symptoms are tied to meal size, meal timing, dose changes, hydration, or something else.

They may not know when to call their provider.

That uncertainty can turn a manageable symptom into a reason to stop.

This does not mean people should push through severe symptoms. Severe abdominal pain, repeated vomiting, dehydration signs, fever, yellowing of the skin or eyes, or symptoms that feel different from a usual pattern should be discussed with a healthcare provider promptly.

But it does mean many people need more guidance than they receive at the prescribing appointment.

Unrealistic expectations can make normal progress feel disappointing

GLP-1 medications are often discussed online through dramatic stories.

Big transformations.

Fast timelines.

Before-and-after photos.

Comments about food noise disappearing overnight.

Those stories may be real for some people, but they are not everyone’s experience.

Some people feel appetite changes quickly. Some notice a gradual shift. Some lose weight steadily. Some lose more slowly. Some have early side effects that complicate food and hydration. Some need time to reach a dose where they notice more change. Some see non-scale improvements before the scale changes much.

When expectations are shaped by social media, normal variation can feel like failure.

Someone may think:

• “Why am I not losing as fast?”
• “Why do I still get hungry?”
• “Why do I feel side effects but not progress?”
• “Why did it work better for my friend?”

Those questions are understandable. But they can lead people to stop early if no one has explained what a realistic range of response can look like.

A slower response does not automatically mean the medication is not working. It may mean the person’s body, dose, timeline, side effects, routines, or medical context are different.

That is a conversation for a healthcare provider, not a reason to quietly disappear from treatment without support.

Plateaus can be mistaken for treatment failure

A plateau can feel discouraging.

You may be doing the same things, taking the same medication, and suddenly the scale stops moving the way it did before.

That can make people wonder whether the medication “stopped working.”

But weight change is rarely linear. The body adapts over time. The pace of change can slow. Some people may see periods where weight stays the same even though appetite, blood sugar, habits, or food noise remain improved.

The scale is one data point. It is not the whole story.

Other signs can matter too:

• Appetite feels more manageable.
• Food noise is quieter.
• Energy is more stable.
• Meals feel less stressful.
• Blood sugar markers are improving.
• Clothes fit differently.
• Walking, stairs, or daily movement feel easier.
• Hydration, protein, fiber, or movement habits are becoming more consistent.
• Side effects are easier to predict or manage.

A plateau is not something to ignore, but it is also not automatically proof that treatment has failed. It is a reason to look at the full picture and talk with your provider about what is happening.

Some people do not realize GLP-1s are often long-term treatment

Another reason people stop is that the medication may be misunderstood as a short course.

Some people think of a GLP-1 like a temporary medication: take it until the goal is reached, then stop.

But many clinicians discuss obesity, type 2 diabetes, and related metabolic conditions as chronic conditions that may require long-term management. For some people, that may include long-term medication. For others, the plan may change over time. The right approach depends on the person, the medication, the reason it was prescribed, side effects, access, goals, and medical history.

This is important because stopping can lead to changes in appetite, weight, blood sugar, or other markers for some people. Clinical trial extension data have shown weight regain after stopping semaglutide, though real-world outcomes can vary and may be influenced by whether someone restarts medication, switches treatments, or has other supports in place.

The key point is not that everyone must stay on a GLP-1 forever.

The key point is that stopping should be a planned medical conversation, not a surprise decision made alone after a frustrating week.

Restarting is common too

Stopping does not always mean someone is done forever.

Recent research suggests many people who stop GLP-1 medications later restart or try another option. That matters because it changes the way we should talk about discontinuation.

For some people, stopping may reflect a temporary barrier: cost, side effects, insurance, supply issues, pregnancy planning, a medical procedure, or a need to reassess the plan.

For others, stopping may reflect a treatment that truly was not the right fit.

Either way, the story is not always “success” or “failure.”

Sometimes the story is: the person needed a better plan, more support, different expectations, clearer medical guidance, or a different option.

The first 90 days can feel lonely

One of the most underestimated reasons people stop is the isolation of navigating the early weeks alone.

Not every question feels big enough to call the doctor.

Not every symptom feels like an emergency.

Not every concern fits neatly into a portal message.

Sometimes the hard part is the accumulation of small uncertainties:

• What can I eat tonight?
• Is this nausea normal?
• Why am I so tired?
• Am I drinking enough water?
• Is this constipation a problem?
• Why did the scale stop moving?
• Should I be worried about this symptom?
• What should I bring up at my next appointment?

When those questions pile up, the journey can start to feel unsupported.

That is the gap many people fall into. Not because they do not care. Not because they lack discipline. Because they are trying to manage a major change with too few touchpoints.

What support can change

Support does not remove every barrier.

It cannot make medication affordable.

It cannot replace your provider.

It cannot make every side effect disappear.

It cannot guarantee a specific result.

But support can change the experience of the first 90 days.

It can help you know what to track.

It can help you notice patterns.

It can help you prepare better questions for your provider.

It can help you understand general GLP-1 information in plain language.

It can help you see progress beyond the scale.

It can help you feel less alone when your appetite, digestion, routines, and expectations are all changing at once.

Most importantly, support can help turn “I cannot do this” into “I need help figuring out what is happening.”

Those are very different moments.

Where Glo fits in

Glo was built for the space between appointments.

The moment when a side effect shows up at night and you want to understand what might be going on.

The moment when you are not sure whether to track something or call your provider.

The moment when the scale has not moved and you need help looking at the bigger picture.

The moment when nothing sounds good, but you know you need to eat something.

The moment when you want to track meals, water, steps, symptoms, appetite, food noise, or energy without turning your life into a spreadsheet.

Glo supports people using doctor-prescribed GLP-1 and GLP-1-related medications. Glo does not prescribe medication, recommend medication changes, diagnose symptoms, tell you whether to continue or stop, or replace your healthcare provider.

What Glo can do is help you organize the day-to-day: what you are feeling, what you are eating, what side effects are showing up, what patterns may be worth noticing, and what questions may be worth bringing to your provider.

The first 90 days can be confusing. They do not have to be unsupported.

The bottom line

Many people stop GLP-1 medications early, and the reasons are often understandable.

Cost can make treatment inaccessible.

Side effects can feel overwhelming.

Expectations can be shaped by unrealistic online stories.

Plateaus can be mistaken for failure.

Some people may not realize these medications are often discussed as long-term treatment.

Many people do not have enough support between appointments.

None of that means someone failed.

It means the first 90 days need more preparation, more context, and more support than many people currently receive.

If you are thinking about stopping your medication, talk with your healthcare provider first. The goal is not to force yourself through something that is not working. The goal is to make the decision with medical guidance, a clearer picture of what is happening, and support that helps you understand your options.